Skip to main content
. 2012 Dec 21;18(47):7063–7069. doi: 10.3748/wjg.v18.i47.7063

Figure 2.

Figure 2

Colonic mucosal matrix metalloproteinase-2 and -9 protein expression in control, AE-941, and ulcerative colitis model groups at different timepoints. The expression of matrix metalloproteinases (MMP)-2 (A) and MMP-9 (B) protein in the colonic mucosa of the ulcerative colitis model group was significantly higher than in the control group (P < 0.05). By days 21 and 56 expression of MMP-2 and MMP-9 in the AE-941 treatment group was significantly less than in the model group (P < 0.05).